These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24019197)

  • 1. Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma.
    Berger WE; Bensch GW; Weinstein SF; Skoner DP; Prenner BM; Shekar T; Nolte H; Teper AA
    Pediatr Pulmonol; 2014 May; 49(5):441-50. PubMed ID: 24019197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease.
    Kosoglou T; Hubbell J; Xuan F; Cutler DL; Meehan AG; Kantesaria B; Wittmer BA
    Int J Chron Obstruct Pulmon Dis; 2013; 8():107-16. PubMed ID: 23525511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects.
    Kosoglou T; Hubbell J; Kantesaria B; Hanson ME; Cutler DL
    Clin Pharmacol Drug Dev; 2014 May; 3(3):229-34. PubMed ID: 27128613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
    Kosoglou T; Hubbell J; Cutler DL; Johnson-Levonas AO; Xu D; Kantesaria BS; Kim K; Miller SD
    Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mometasone furoate (MF) improves lung function in pediatric asthma: A double-blind, randomized controlled dose-ranging trial of MF metered-dose inhaler.
    Amar NJ; Shekar T; Varnell TA; Mehta A; Philip G
    Pediatr Pulmonol; 2017 Mar; 52(3):310-318. PubMed ID: 27740721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device.
    Kosoglou T; Hubbell J; Johnson-Levonas AO; Yunan M; Kantesaria BS; Cutler DL
    Clin Pharmacol Drug Dev; 2014 May; 3(3):222-8. PubMed ID: 27128612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
    D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H
    Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
    Berger WE; Milgrom H; Chervinsky P; Noonan M; Weinstein SF; Lutsky BN; Staudinger H
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma.
    Nolte H; Pavord I; Backer V; Spector S; Shekar T; Gates D; Nair P; Hargreave F
    Respir Med; 2013 May; 107(5):656-64. PubMed ID: 23490226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mometasone furoate/formoterol in the treatment of persistent asthma.
    Berger WE
    Expert Rev Respir Med; 2011 Dec; 5(6):739-46. PubMed ID: 22082160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids.
    Nathan RA; Nolte H; Pearlman DS;
    Allergy Asthma Proc; 2010; 31(4):269-79. PubMed ID: 20678306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg and 400/10 microg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids.
    Weinstein SF; Corren J; Murphy K; Nolte H; White M;
    Allergy Asthma Proc; 2010; 31(4):280-9. PubMed ID: 20687982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
    Miller CJ; Senn S; Mezzanotte WS
    Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
    Harnest U; Price D; Howes T; Sussman G
    J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate.
    Nathan RA; Nayak AS; Graft DF; Lawrence M; Picone FJ; Ahmed T; Wolfe J; Vanderwalker ML; Nolop KB; Harrison JE
    Ann Allergy Asthma Immunol; 2001 Feb; 86(2):203-10. PubMed ID: 11258691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination.
    LaForce C; Weinstein C; Nathan RA; Weinstein SF; Staudinger H; Meltzer EO
    J Asthma; 2011 Aug; 48(6):625-31. PubMed ID: 21726121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.
    Nayak AS; Banov C; Corren J; Feinstein BK; Floreani A; Friedman BF; Goldsobel A; Gottschlich GM; Hannaway PJ; Lampl KL; Lapidus RJ; Lawrence M; Lumry W; Munk Z; Pearlman D; Scardella AT; Schenkel EJ; Segal AT; Segall N; Silverman B; Shneyer L; Nolop KB; Harrison JE
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):417-24. PubMed ID: 10795650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide.
    Berger WE; Gillen M; Eckerwall G; Uryniak T; Trudo FJ; Lampl KL
    Allergy Asthma Proc; 2014; 35(2):134-40. PubMed ID: 24717790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.